ADAditi Deshpande

Aditi Deshpande

*This is an algorithmically generated author record based on publicly available information.

Aditi Deshpande has a total of 75 co-authors. Here are the top co-authors by number of shared publications:

  • Alexandra Lepier

    Department of Physiological Genomics, Institute of Physiology, Ludwig-Maximilian University of Munich, Schillerstrasse 46, 80336 Munich, Germany

    2 shared publications
  • Assem Duisembekova

    CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon 3 , Lyon

    2 shared publications
  • Benedikt Berninger

    Physiological Genomics, Biomedical Center Ludwig-Maximilians-University Munich, 80336 Munich, Germany; Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, 55128 Mainz, Germany; Focus Program Translational Neuroscience, Johannes Gutenberg University Mainz, 55128 Mainz, Germany

    2 shared publications
  • Bénédicte F. Py

    CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France

    2 shared publications
  • Dieter Chichung Lie

    Institute of Biochemistry, Emil Fischer Center, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany

    2 shared publications
  • Dominic Ferber

    Institute of Structural Biology, University of Bonn, Venusberg Campus 1, 53127 Bonn, Germany

    2 shared publications

Latest Publications

  • Open Access

    Discovery of potent and selective inhibitors of human NLRP3 with a novel mechanism of action

    by Kevin Wilhelmsen, Aditi Deshpande, Sarah Tronnes, Maitriyee Mahanta, Matthew Banicki, Mary Cochran, Samantha Cowdin, Kristen Fortney, George Hartman, Robert E. Hughes, et al.

    The NLRP3 inflammasome is an intracellular protein complex that causes inflammation via the release of IL-1β and pyroptosis. NLRP3 activation is associated with many age-related inflammatory diseases, and NLRP3 inhibition is a promising therapeutic strategy. We previously performed a DNA-encoded library screen to identify novel NLRP3-binding molecules. Herein we describe the characterization of BAL-0028 as a potent and specific inhibitor of NLRP3 signaling. Notably, BAL-0028 is a poor inhibitor of mouse NLRP3 but inhibits human and primate NLRP3 with nanomolar potency. Using cellular and biochemical analyses, we demonstrate that BAL-0028 binds to the NLRP3 NACHT domain at a site that is distinct from the MCC950-binding pocket. Using humanized NLRP3 mice, we show that a derivative of BAL-0028, BAL-0598, inhibits NLRP3 activation in vivo in a peritonitis model. Finally, we demonstrate that both BAL-0028 and BAL-0598 inhibit select hyperactive NLRP3 mutations associated with autoinflammatory diseases more potently than MCC950. BAL-0028 and BAL-0598 thus represent a new modality for NLRP3 inhibition in inflammatory diseases.


  • Open Access

    Inhibition of NLRP3 by a CNS-penetrating indazole scaffold

    by Jane Torp, Dominic Ferber, Hannes Buthmann, Gregor Hagelueken, Aditi Deshpande, George Hartman, Robert E. Hughes, Taiz Salazar, Sarah Tronnes, Assem Duisembekova, et al.

    Low-grade inflammation is a hallmark of ageing and a key cause of age-related impairments and diseases 1 . The NOD-like receptor NLRP3 senses a variety of danger signals and environmental insults, resulting in pro-inflammatory response, inflammasome formation and pyroptosis 2,3 . Its aberrant activation has been linked to many acute and chronic diseases ranging from atherosclerosis to Alzheimer’s disease and cancer, making NLRP3 an attractive therapeutic target 4,5 . Here we report the discovery, characterization, and structure of an indazole-based NLRP3 antagonist, BAL-1516, which potently inhibits inflammasome formation in monocytes and microglia. The cryo-electron microscopy structure of BAL-1516 bound to NLRP3 reveals a previously undescribed compound binding site at a surface groove of the nucleotide-binding domain with contacts to the FISNA and WHD subdomains. The characteristic feature of BAL compound binding is the formation of three hydrogen bonds to the peripheral β-strand of the triple-ATPase; two from the indazole’s nitrogen atoms and a third from the compounds’ linker region. Additional phenyl and thiazole moieties render the compound hydrophobic, allowing excellent blood-brain barrier penetration. The compound binding site is highly specific for NOD-like receptors, and the optimized compound BAL-1516 is able to directly bind mouse NLRP3 despite two conservative residue changes in the binding interface. The BAL compounds represent a first-in-class family of NLRP3 inhibitors, providing a broad design space, including covalent and degradative properties, for the development of NLRP3-directed therapeutics. The innate immune system contains cytosolic proteins that sense cellular stress caused by bacterial, viral and fungal infections or sterile inflammation, to control cellular integrity 2 . NLRP3 is a well-studied member of the nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) that is involved in the activation of the inflammasome, a multiprotein complex that mediates inflammation 6 . Upon detection of stress or pathogen-associated signals, NLRP3 triggers the activation of caspase-1, which leads to the production of pro-inflammatory cytokines such as IL-1β and IL-18, driving inflammatory responses and ultimately pyroptotic cell death. In the context of neuroinflammation, NLRP3 plays a significant role in the pathogenesis of various neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis 7 . Research into targeting NLRP3 signalling with CNS-penetrating molecules holds potential for developing therapeutic strategies to alleviate neuroinflammatory conditions and to slow the progression of neurodegenerative diseases.


  • Recurrent reciprocal copy number variants: Roles and rules in neurodevelopmental disorders

    by Aditi Deshpande, Lauren A. Weiss

    Deletions and duplications, called reciprocal CNVs when they occur at the same locus, are implicated in neurodevelopmental phenotypes ranging from morphological to behavioral. In this article, we propose three models of how differences in gene expression in deletion and duplication genotypes may result in deleterious phenotypes. To explore these models, we use examples of the similarities and differences in clinical phenotypes of five reciprocal CNVs known to cause neurodevelopmental disorders: 1q21.1, 7q11.23, 15q13.3, 16p11.2, and 22q11.2. These models and examples may inform some insights into better understanding of gene–phenotype relationships. © 2018 Wiley Periodicals, Inc. Develop Neurobiol 78: 519–530, 2018


  • Open Access

    Cellular Phenotypes in Human iPSC-Derived Neurons from a Genetic Model of Autism Spectrum Disorder

    by Aditi Deshpande, Smita Yadav, Dang Q. Dao, Zhi-Yong Wu, Kenton C. Hokanson, Michelle K. Cahill, Arun P. Wiita, Yuh-Nung Jan, Erik M. Ullian, Lauren A. Weiss


  • Identification and Successful Negotiation of a Metabolic Checkpoint in Direct Neuronal Reprogramming

    by Sergio Gascón, Elisa Murenu, Giacomo Masserdotti, Felipe Ortega, Gianluca L. Russo, David Petrik, Aditi Deshpande, Christophe Heinrich, Marisa Karow, Stephen P. Robertson, et al.


  • Open Access

    In Vivo Targeting of Adult Neural Stem Cells in the Dentate Gyrus by a Split-Cre Approach

    by Ruth Beckervordersandforth, Aditi Deshpande, Iris Schäffner, Hagen B. Huttner, Alexandra Lepier, Dieter Chichung Lie, Magdalena Götz


  • Oligodendrogliogenic and neurogenic adult subependymal zone neural stem cells constitute distinct lineages and exhibit differential responsiveness to Wnt signalling

    by Felipe Ortega, Sergio Gascón, Giacomo Masserdotti, Aditi Deshpande, Christiane Simon, Judith Fischer, Leda Dimou, D. Chichung Lie, Timm Schroeder, Benedikt Berninger

    The adult mouse subependymal zone (SEZ) harbours adult neural stem cells (aNSCs) that give rise to neuronal and oligodendroglial progeny. However it is not known whether the same aNSC can give rise to neuronal and oligodendroglial progeny or whether these distinct progenies constitute entirely separate lineages. Continuous live imaging and single-cell tracking of aNSCs and their progeny isolated from the mouse SEZ revealed that aNSCs exclusively generate oligodendroglia or neurons, but never both within a single lineage. Moreover, activation of canonical Wnt signalling selectively stimulated proliferation within the oligodendrogliogenic lineage, resulting in a massive increase in oligodendrogliogenesis without changing lineage choice or proliferation within neurogenic clones. In vivo activation or inhibition of canonical Wnt signalling respectively increased or decreased the number of Olig2 and PDGFR- α positive cells, suggesting that this pathway contributes to the fine tuning of oligodendrogliogenesis in the adult SEZ.


  • Retrograde monosynaptic tracing reveals the temporal evolution of inputs onto new neurons in the adult dentate gyrus and olfactory bulb

    by Aditi Deshpande, Matteo Bergami, Alexander Ghanem, Karl-Klaus Conzelmann, Alexandra Lepier, Magdalena Götz, Benedikt Berninger

    Significance: New neurons are constantly added to the hippocampus and the olfactory bulb. These neurons are believed to fulfill unique functions during their early life compared with mature neurons, which may depend on the way they are connected. Here we studied the stepwise integration of new neurons within these two brain areas using a rabies-virus–based synaptic tracing tool. Our study revealed that in both areas integration follows a similar logic, with adult-born neurons incorporating first into the local circuit before becoming innervated by long-range connections. This changing pattern of presynaptic connectivity likely contributes to adult-born neurons’ functions.